C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer.
C6001001
Phase 1 other active
Quick answer
C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer. for Non-muscle invasive bladder cancer (NMIBC) is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Non-muscle invasive bladder cancer (NMIBC)
- Phase
- Phase 1
- Modality
- other
- Status
- active